Posts in Category: data

LUMEDX Blog 

LUMEDX showcases data intelligence tools at HIMSS18

LUMEDX will be demonstrating its powerful analytics and data management tools at the HIMSS Annual Conference & Exhibition, where more than 45,000 healthcare professionals from more than 90 countries will gather for the premier health information and technology conference.

Scheduled for March 5-9 at the Venetian-Palazzo-Sands Expo Center in Las Vegas, HIMSS18 is a one-stop shop for the education, innovation and collaboration professionals need to continue the transformation of healthcare through IT.

Come by Booth 12340, Level 1, Hall G, to learn how LUMEDX’s data intelligence solutions can help achieve better performance while reducing costs. Click here to schedule a demonstration of how meaningful analytics can monitor, measure and improve all aspects of cardiovascular services.

Exhibition Hall hours are limited to 9:30 a.m.-6 p.m. Tuesday and Wednesday, and 9:30 a.m.-4 p.m. Thursday.

Throughout the conference, HIMSS18 will include a full slate of networking opportunities, five keynote addresses, government sessions, specialty education tracks and more. Data Analytics/Clinical and Business Intelligence is one of 23 in-depth topics that will be explored in the 300-plus educational sessions being offered.

Other subject matters to be tackled include:

  • Improving Quality Outcomes Through Health IT
  • Health Information Exchange, Interoperability and Data Integration
  • Privacy, Security and Cybersecurity
  • Emerging Payment Models for Value-Based Care
  • Process Improvement, Workflow, Change Management

For more information about educational sessions, keynote speakers or registration, please visit www.himssconference.org.

Posted by Jana Ballinger Monday, February 12, 2018 9:25:00 AM Categories: analytics data healthcare analytics HIMSS

LUMEDX Blog 

Value-based care is here to stay, will get boost from analytics, study says

Despite 2017’s cancellation of mandatory bundled payments, the value-based care movement in the United States is still healthy and will benefit in 2018 from analytics, according to a report from Washington, D.C.-based healthcare consulting firm Avalere.

In “2018 Healthcare Industry Outlook,” Avalere says new ways to collect data and advanced analytic capabilities are revitalizing efforts to turn data into insights that can inform policy and improve clinical workflows. This supports the shift to value-based care, which has continued even as the Trump administration backs away from large-scale mandatory models.

In November, the Centers for Medicare and Medicaid Services (CMS) canceled a plan for mandatory hip fracture and cardiac bundled payments that was slated to go into effect Jan. 1, sparking some concern that the action signaled a move away from value-based care. But then on Jan. 9, the CMS launched a new, voluntary bundled payment model that will be considered an alternative payment model (APM) for purposes of Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) reporting.

This, along with evidence from Avalere that the private sector has not reversed course, tells us that interest in strategies to move away from the traditional fee-for-service payment model has not waned.

“Despite political transitions and revisions to Medicare bundled payment programs, the U.S. healthcare system’s transition to APMs has remained steady,” the report says. In 2017, some of the largest commercial plans were running nearly 50 percent of their medical spend through APMs and aim to go higher, according to Avalere.

Because value-based care rewards healthcare providers who prioritize better outcomes for their patients, leaders are turning to technology investments that can lower costs and improve care quality. Avalere says that data reliability and accessibility, including capturing information and creating algorithms, will drive outcomes-based contracting and a transition toward APMs.

“Success in APMs will require providers to create better infrastructure for proactive care management, data analytics, and timely integration of disparate data,” the report says. “More widespread availability of real-world data will enable new entities to leverage analytics and insight to benefit patients and their providers.”

An outcomes-driven environment requires fast and easy access to clinical and financial intelligence that can shine a light on the best possible course forward. To learn how LUMEDX data analytics can help your organization in the transition to value-based care by becoming more efficient and improving patient satisfaction, get information about the Cardiovascular Performance Program or email us at info@lumedx.com.

LUMEDX Blog 

Full-scale adoption of AI still a long way away, new study says

While the use of clinical and business intelligence tools is on the rise in healthcare, the hype surrounding artificial intelligence is unlikely to lead to full-scale adoption for quite some time, according to a new study by the Healthcare Information and Management Systems Society (HIMSS).

In the HIMSS 2017 Essentials Brief: Clinical and Business Intelligence, 23.5 percent of respondents said they expect their organizations to begin using AI within two years, 24.7 percent said within the next three to five years and 8.2 percent said six to 10 years. Only 4.7 percent said their organizations were already using AI and just 10.6 percent said they expect their organizations to begin leveraging AI within the next 12 months.

The prevailing belief seems to be that the technology just isn’t ready yet. Some 37 percent of respondents said further AI development is needed, 23.5 percent said the business case for AI was still unproven and 19.8 percent cited infrastructure constraints within their organizations. When questioned about barriers in the industry overall, 50 percent of respondents said they believe the technology is still in development and current opportunities to apply it to healthcare are difficult to understand.

Here are some of the other findings:

  • Clinical and Business Intelligence solution adoption rates for the U.S. healthcare market in 2017 are 48 percent and 62 percent, respectively.
  • Data governance, an important pre-requisite for the success of data analytics, has shown significant improvement in the “highly optimized” and “strong” categories from study respondents who were asked to qualify their efforts in this area.
  • While leveraging clinical analytics to meet Meaningful Use (MU) requirements and reporting remains the primary area of focus (nearly 70 percent of respondents), there has been an increase in the focus on population health year over year from roughly 20 percent in 2016 to 30 percent in 2017.

To learn more about the HIMSS findings, download the study here.

Clinical and financial business intelligence solutions have become essential to healthcare organizations in the move from volume to value-based care and in the development of new models of care. LUMEDX offers comprehensive, integrated cardiovascular data intelligence and imaging solutions—all with seamless connectivity to your enterprise systems (EHR/HIS).

For more information, download the Cardiovascular Performance Program Info Pack.

Posted by Jana Ballinger Monday, November 13, 2017 10:23:00 AM Categories: analytics data EHR HIMSS value-based purchasing

LUMEDX Blog 

How near-real time and even retrospective analytics can improve performance

People who work in cardiovascular departments know that retrospective clinical data is essential in the quest to improve outcomes and contain costs, but even more valuable is integrated, near real-time data analytics that illustrate how you compare to other cardiac care centers nationally.

“It’s good to be able to understand ‘this is how I did’—but that’s really reporting the news,” says LUMEDX analytics consultant Rachanee Curry, FACHE. “It’s better to be able to have real-time feedback and to be able to change your performance, finding opportunities for improvement as you go along.”

However, retrospective and real-time or even prospective analytics can all deliver crucial insights to hospitals. Even data collected for the Society of Thoracic Surgeons (STS) and the American College of Cardiology’s National Cardiovascular Data Registry® (ACC NCDR) can be used to understand service line performance, view outliers and identify root causes. These are the insights that enable improvement.


Rachanee Curry, LUMEDX analytics consultant, talks about the kinds of insights that can enable improved outcomes and reduced costs.

“Being able to focus in on those areas where your program is performing differently than best practices means you can improve the processes of care that lead to these variances and that will invariably lead to improved clinical outcomes,” Curry says.

LUMEDX offers data analytics solutions that enable physicians and service line leaders to monitor, measure, and improve all aspects of cardiovascular services—to help drive performance while reducing costs. LUMEDX is also the No. 1 provider of ACC and STS Registry Software. To learn more, email info@lumedx.com.


Posted by Jana Ballinger Monday, October 16, 2017 9:30:00 AM Categories: ACC data healthcare analytics NCDR performance Society of Thoracic Surgeons STS

LUMEDX Blog 

Don’t let obsolete devices jeopardize your medical data

As anyone with a mobile phone can attest, technology is moving so fast it doesn’t take long for the next big thing to become antiquated. This rapid rate of change creates many challenges, and one of the most critical is the retention of important information even as the devices collecting and storing that information become obsolete.

In fact, a study by the University of British Columbia tracking the accessibility of scientific data over time found that 80 percent is lost within two decades thanks to outmoded storage devices and old email addresses.

Now imagine all the clinical and operational data that’s collected within hospital walls, data that must be retained when new technology and new clinical devices are installed. 


Mickey Norris, LUMEDX Southeast Sales VP and General Manager, talks about preserving crucial data.

“As devices become obsolete, we remove them from service and bring in something new,” says Mickey Norris, Southeast Sales VP and General Manager at LUMEDX. “But the problem is that when you remove these devices from service, you’re also removing all the data they collected in the past. So, as you throw out the device you risk throwing out years of relevant data.”

While some device information is transmitted to another system, like an EHR, if it is not captured as discrete data it is not available for analysis. This problem can be avoided by extracting discrete data elements, he says. LUMEDX’s database is designed to extract more than 20,000 data elements from the start, according to Norris.

“We believe that any piece of information that’s collected is going to be relevant. Maybe you don’t see the value of that data point today, but you will in the future,” he added. “Most of the time we don’t know what’s going to be relevant in the future, but if we’ve collected it we can take that information and act upon it in the future.”

With meaningful analytics that enable you to monitor, measure and improve all aspects of cardiovascular information services, LUMEDX's data intelligence tools and packages help drive performance while reducing costs.

Email info@lumedx.com to learn more about LUMEDX HealthView workflow solutions.

Posted by Jana Ballinger Tuesday, September 05, 2017 1:16:00 PM Categories: data devices health information technology

LUMEDX Blog 

3 ways to get buy-in for predictive analytics tools

analytics

Predictive analytics promise better outcomes and lower costs—but they can’t deliver if the tools aren’t being fully embraced.

Getting service line leaders and physicians to use predictive analytics is sometimes more difficult than you’d think, even though the National Academy of Medicine says one-third of the U.S. healthcare system’s resources—$750 billion each year—is spent on unnecessary services and inefficient care. So what’s standing in the way of getting buy-in when it comes to the kind of tools specifically designed to reduce wasteful spending?

Meetali Kakad, Ronen Rozenblum and David Westfall Bates, writing for the Harvard Business Review, interviewed 34 key figures from leading U.S. health systems, policy makers and predictive analytics vendors to find out how to get more buy-in. Here are some of the lessons learned:

1. Engage everyone. “Success depends less on the tool itself than on getting buy-in at all levels from the start,” they wrote. This includes making sure frontline employees fully understand the value of these analytics, as well as ensuring your CEOs and top leadership are educated and fully grasp the value proposition to generate support. 

2. Communicate the value. “Demonstrating the clinical impact of a predictive tool can go a long way toward engaging those who will use them,” the authors say. Giving real examples that are results-oriented is especially helpful for clinical staff who may be skeptical of “black box algorithms.”

3. Bring in the experts. The use of implementation experts to help everyone adjust gives you a marked advantage, according to the authors’ findings. These experts can work with clinicians to map workflows and spot potential challenges when introducing a new process or tool.

LUMEDX, the leader in cardiovascular data intelligence and a pioneer in cloud-powered healthcare solutions, offers a comprehensive suite of software and services that enable meaningful analytics, high-performance workflows, optimal integration of clinical and HIS data, and improved continuity of care.

For more information on LUMEDX HealthView solutions, please visit www.lumedx.com or email info@lumedx.com.

Posted by Jana Ballinger Tuesday, July 18, 2017 9:15:00 AM Categories: analytics data health information technology

LUMEDX Blog 

How real-time analytics can lead to better outcomes, lower costs

The United States health care system consistently racks up higher costs but fails to produce better outcomes, according to Mirror, Mirror 2017: International Comparison Reflects Flaws and Opportunities for Better U.S. Health Care.

Eleven of the world’s most prosperous nations—Australia, Canada, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland and the United Kingdom, plus the United States—are included in the most recent report from the Commonwealth Fund. The United States is last in efficiency; the U.S. spent $9,364 per person on healthcare in 2016, compared to $4,094 in the U.K., which ranked first on performance overall.


Praveen Lobo, LUMEDX Vice President of Strategic Products, talks about the importance of
near real-time data analytics.

With physicians and service line leaders alike working on the front lines to improve this, having near real-time data analytics available at your fingertips is paramount, says Praveen Lobo, vice president of strategic products at LUMEDX.

“When you want to improve your core parameters that you’re playing with—your outcomes and your costs—the sooner you know information about these two key metrics, the better you can affect change,” Lobo says.

Waiting for monthly or quarterly reports just isn’t an option anymore. “Retroactive data is delayed,” he says, adding that by the time reports come out so much has happened and “there’s already a lot of money that has bled by that time.”

LUMEDX helps heart hospitals collect point-of-care data and delivers actionable insights, facilitating better clinical decision-making and helping to improve business operations through increased efficiency and cost savings. For more information about LUMEDX’s approach to cardiovascular performance improvement, request a Complete Cardiovascular Performance Plan Info Pack.

Posted by Jana Ballinger Monday, July 10, 2017 9:32:00 AM Categories: analytics data

LUMEDX Blog 

Why clinical insights eclipse raw data

analyticsHealthcare providers are realizing that massive amounts of data don't do anyone any good unless this data is distilled into relevant information that improves quality of care and helps contain or reduce costs.

In fact, companies that just sell information won't last long unless they turn that raw data into analytics and clinical insights, according to an article written by three managing directors of L.E.K. Consulting and published in the Harvard Business Review.

One option is to become the authoritative source for a particular kind of information, the article says, but a better solution is to evolve from providing data to deriving insight -- transforming information to support better decisions.

"In healthcare, providers don't want data, they want solutions that lower costs and improve outcomes," the authors wrote. "(Healthcare IT) firms that deliver those solutions are the ones that will be around in five years' time."

LUMEDX, the leader in cardiovascular data intelligence and a pioneer in cloud-powered healthcare solutions, offers a comprehensive suite of technology and services that enable meaningful analytics, streamlined CV workflows, and optimal integration of clinical and EHR data. The data our systems collect and transmit can be leveraged into real-time performance insights, enabling better healthcare, reduced costs, and the best measure of good data: positive outcomes.

For more information about how we help our customers make the leap from data to insight, read about our Cardiovascular Performance Program.

Posted by Jana Ballinger Wednesday, June 21, 2017 2:49:00 PM Categories: analytics data Lumedx

Data accessibility viewed as key to closing the gap between value-based care and health IT 

​Although much progress has been achieved in digitizing the healthcare system, today's health IT infrastructure still struggles to support a transition to "value-based care," according to a new report from the American Medical Informatics Association.

"Provider organizations pursuing new models of health care delivery and payment are finding that their electronic systems lack the capabilities needed to succeed," the study asserted. "The result is a chasm between the current health IT ecosystem and the health IT ecosystem that is desperately needed."

The report, titled, "Crossing the health IT chasm: considerations and policy recommendations to overcome current challenges and enable value-based care," outlines policy recommendations for patients, providers and researchers to improve access to healthcare data for all the groups and proposes new standards for IT systems and applications.

LUMEDX, the leader in cardiovascular data intelligence and a pioneer in cloud-powered healthcare solutions, offers a comprehensive suite of software and services enables meaningful analytics, high-performance workflows, optimal integration of clinical and HIS data, and improved continuity of care.

For more information on LUMEDX HealthView solutions, please visit www.lumedx.com or email info@lumedx.com.​

Report shows registries advancing patient care for heart patients  

Two doctors inserting stent Registries continue to improve the effectiveness and safety of patient care of heart disease in hospitals throughout the U.S.

A recent report shows registry data is providing unique perspectives into the care and outcomes of heart disease and outlines the strength of national quality programs, like NCDR, in advancing the effectiveness of patient treatments.

Published in the Journal of the American College of Cardiology, the study addressed trends in heart disease care from the American College of Cardiology's National Cardiovascular Data Registry.

The authors examined patient populations, participating centers and patterns of care based on 2014 data from four of the 10 NCDR programs -- CathPCI Registry, ICD Registry, ACTION Registry-GWTG and IMPACT Registry.

"We were able to report on the care and outcomes of patients undergoing common cardiovascular procedures, including percutaneous coronary interventions, implantable defibrillators, and interventions for congenital heart disease as well as for patients with acute heart attacks," NCDR Management Board Chair and lead author of the study Frederick A. Masoudi, MD, MSPH, FACC , said. "In some cases, hospitals are consistently providing excellent care; the registries, however, allow us to identify those aspects of care where the cardiovascular clinical community can improve."

The full report can be accessed here.

LUMEDX, as the leading independent provider of ACC and STS registry software, believes registries are key to Cardiovascular Information Systems. For more information about LUMEDX registry solutions, view a video highlighting LUMEDX Registry Interoperability.

 

Page 1 of 8 1 2 3 4 5 6 7 8 > >>
  • RSS

Statistics

  • Entries (233)
  • Comments (924)

Categories